Accipiter Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-100,000
| Closed | -$2.43M | – | 6 |
|
|
2018
Q2 | $2.43M | Sell |
100,000
-47,571
| -32% | -$1.16M | 0.79% | 6 |
|
|
2018
Q1 | $2.52M | Sell |
147,571
-276,493
| -65% | -$4.73M | 5.32% | 4 |
|
|
2017
Q4 | $8.04M | Sell |
424,064
-180,121
| -30% | -$3.41M | 16.34% | 2 |
|
|
2017
Q3 | $10.6M | Buy |
604,185
+402,040
| +199% | +$7.08M | 21.87% | 2 |
|
|
2017
Q2 | $6.72M | Buy |
202,145
+2,145
| +1% | +$71.3K | 14.02% | 2 |
|
|
2017
Q1 | $6.42M | Sell |
200,000
-4,030
| -2% | -$129K | 10.99% | 2 |
|
|
2016
Q4 | $7.4M | Buy |
204,030
+28,117
| +16% | +$1.02M | 5.88% | 5 |
|
|
2016
Q3 | $8.09M | Buy |
175,913
+1,290
| +0.7% | +$59.4K | 3.92% | 6 |
|
|
2016
Q2 | $8.77M | Sell |
174,623
-24,817
| -12% | -$1.25M | 7.17% | 6 |
|
|
2016
Q1 | $10.7M | Buy |
199,440
+66,652
| +50% | +$3.57M | 6.1% | 5 |
|
|
2015
Q4 | $8.72M | Buy |
+132,788
| New | +$8.72M | 4.76% | 11 |
|
|
2014
Q3 | $4.46M | Sell |
83,035
-163
| -0.2% | -$8.76K | 8% | 8 |
|
|
2014
Q2 | $4.36M | Buy |
83,198
+16,840
| +25% | +$883K | 8.06% | 6 |
|
|
2014
Q1 | $3.51M | Sell |
66,358
-282,436
| -81% | -$14.9M | 7.96% | 5 |
|
|
2013
Q4 | $14M | Sell |
348,794
-89,378
| -20% | -$3.58M | 17.81% | 3 |
|
|
2013
Q3 | $16.6M | Buy |
438,172
+75,404
| +21% | +$2.85M | 15.21% | 2 |
|
|
2013
Q2 | $14.2M | Buy |
+362,768
| New | +$14.2M | 11.16% | 4 |
|